Our Technologies

Xenomimetics LLC’s Technology

Xenomimetics Has developed and validated a novel tumor xenograft platform. We anticipate that this platform will be transformative both for predicting the individual cancer patients responses to traditional chemotherapy and novel immunotherapies The effectiveness of immune-based cancer therapies in the preclinical setting.

We gratefully acknowledge the support of our Venture partners.

Together we can do great things.